United States of America: President signed Executive Order 14195 addressing duty-free de minimis treatment under customs duties

On 1 February 2025, the President signed Executive Order 14195 on Imposing Duties To Address the Synthetic Opioid Supply Chain in the People's Republic of China, which includes provisions addressing duty-free de minimis treatment under customs duties. The executive order terminates the duty-free entry of goods valued under USD 800, with a view to enhancing tariff enforcement and limiting tariff evasion. This action forms part of a broader strategy to combat the illicit drug trade, with a particular focus on synthetic opioids originating from China, and to enhance trade enforcement. The order also imposes new tariffs on Chinese imports and directs Homeland Security and other agencies to monitor China's actions and recommend further measures if necessary.